A detailed history of Bank Of America Corp transactions in Cytosorbents Corp stock. As of the latest transaction made, Bank Of America Corp holds 34,443 shares of CTSO stock, worth $31,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,443
Previous 34,451 0.02%
Holding current value
$31,687
Previous $24,000 112.5%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.55 $5 - $12
-8 Reduced 0.02%
34,443 $51,000
Q2 2024

Aug 14, 2024

SELL
$0.7 - $1.01 $1,712 - $2,471
-2,447 Reduced 6.63%
34,451 $24,000
Q1 2024

May 15, 2024

SELL
$0.86 - $1.07 $25,698 - $31,973
-29,882 Reduced 44.75%
36,898 $35,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $1.94 $911 - $1,637
-844 Reduced 1.25%
66,780 $74,000
Q2 2023

Aug 14, 2023

SELL
$2.37 - $3.65 $3,654 - $5,628
-1,542 Reduced 2.23%
67,624 $242,000
Q1 2023

May 12, 2023

SELL
$1.79 - $4.17 $8,330 - $19,407
-4,654 Reduced 6.3%
69,166 $233,000
Q4 2022

Feb 10, 2023

SELL
$1.03 - $2.03 $7,889 - $15,549
-7,660 Reduced 9.4%
73,820 $114,000
Q3 2022

Nov 14, 2022

SELL
$1.2 - $2.46 $35,709 - $73,204
-29,758 Reduced 26.75%
81,480 $111,000
Q2 2022

Aug 12, 2022

BUY
$1.76 - $3.22 $120,827 - $221,059
68,652 Added 161.21%
111,238 $243,000
Q1 2022

May 16, 2022

SELL
$2.88 - $4.23 $50,912 - $74,777
-17,678 Reduced 29.33%
42,586 $136,000
Q4 2021

Feb 08, 2022

BUY
$4.05 - $8.11 $129 - $259
32 Added 0.05%
60,264 $252,000
Q3 2021

Nov 15, 2021

SELL
$7.0 - $9.71 $6,944 - $9,632
-992 Reduced 1.62%
60,232 $489,000
Q2 2021

Sep 13, 2021

BUY
$7.55 - $9.42 $462,241 - $576,730
61,224 New
61,224 $462,000

Others Institutions Holding CTSO

About Cytosorbents Corp


  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $40.1M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.